Latest1 information on COVID-19
©2022 Stanford Medicine
Not Recruiting
Trial ID: NCT01617954
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Susy Yuan-Huey Hung Professor
Inclusion Criteria:
- Women with histologically proven invasive stage I-II, node negative, hormone receptor
positive, Her2 negative breast cancer, who received an Oncotype DX intermediate score
(18-30)
- ≥ 18 years of age at time of consent
- Written informed consent
Exclusion Criteria:
- Insufficient tissue remaining for Mammaprint FFPE
- Tumor sample shipped to Agendia with ≤ 30% tumor cells or that fails QA or QC criteria
- Women who have started or completed adjuvant chemotherapy or neo-adjuvant chemotherapy
device: MammaPrint
Not Recruiting
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Annabel Castaneda
650-498-7977